Archer Investment Corporation’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Archer Investment Corporation’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235	Hold	350	–	–	﹤0.01%	1168
2026 Q1	$119	Hold	350	–	–	﹤0.01%	1188
2025 Q4	$245	Hold	350	–	–	﹤0.01%	1112
2025 Q3	$945	Hold	350	–	–	﹤0.01%	1071
2025 Q2	$1.01K	Hold	350	–	–	﹤0.01%	1033
2025 Q1	$343	Hold	350	–	–	﹤0.01%	1063
2024 Q4	$175	Hold	350	–	–	﹤0.01%	1081
2024 Q3	$1.31K	Hold	350	–	–	﹤0.01%	952
2024 Q2	$1.96K	Hold	350	–	–	﹤0.01%	908
2024 Q1	$1.83K	Hold	350	–	–	﹤0.01%	903
2023 Q4	$1.83K	Hold	350	–	–	﹤0.01%	910
2023 Q3	$5.52K	Buy	350 +57	+19%	+$1.02K	﹤0.01%	732
2023 Q2	$5.7K	Hold	293	–	–	﹤0.01%	723
2023 Q1	$8.31K	Buy	+293	New	+$8.7K	﹤0.01%	588

Other funds holding EGRX

SLG

Stanley-Laman Group Berwyn, Pennsylvania $984M AUM 72.08% 1-Year Est. Return

Archer Investment Corporation's EGRX Position: Q2 2026 in Review

Archer Investment Corporation held its Eagle Pharmaceuticals, Inc. (EGRX) position steady in Q2 2026 at 350 shares worth $235. The position accounts for ﹤0.01% of the portfolio, ranked #1168.

Archer Investment Corporation first reported a position in EGRX in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.31K in Q1 2023. 2 funds tracked by Wall St. Rank hold EGRX as of Q2 2026.

Archer Investment Corporation held 350 shares of Eagle Pharmaceuticals, Inc. worth $235 as of Q2 2026.
Archer Investment Corporation left its Eagle Pharmaceuticals, Inc. share count unchanged in Q2 2026.
Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #1168 holding.
Archer Investment Corporation first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2023 and has held it in 14 quarters since.
Archer Investment Corporation's Eagle Pharmaceuticals, Inc. position peaked at $8.31K in Q1 2023.
2 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.